Penn Capital Management Company, LLC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 188 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.

Quarter-by-quarter ownership
Penn Capital Management Company, LLC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$12,020,000
+9.0%
276,378
-4.6%
1.18%
+11.1%
Q1 2019$11,030,000
-10.4%
289,812
+29.0%
1.07%
-12.5%
Q4 2018$12,308,000
-25.0%
224,739
-15.3%
1.22%
-2.2%
Q3 2018$16,416,000
+48.7%
265,255
-22.3%
1.25%
+51.5%
Q2 2018$11,041,000
-10.4%
341,580
-13.0%
0.82%
-15.1%
Q1 2018$12,328,000
-19.9%
392,515
+17.4%
0.97%
-9.8%
Q4 2017$15,385,000
+48.0%
334,297
+21.6%
1.07%
+41.3%
Q3 2017$10,398,000
-10.2%
274,842
+13.4%
0.76%
-11.7%
Q2 2017$11,575,000
+3461.5%
242,293
+3528.2%
0.86%
+3813.6%
Q1 2017$325,0006,6780.02%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Key Colony Management, LLC 134,600$13,045,00011.31%
Biondo Investment Advisors, LLC 279,717$27,110,0008.33%
GILDER GAGNON HOWE & CO LLC 3,177,130$307,927,0004.48%
DARUMA CAPITAL MANAGEMENT LLC 814,470$78,938,0003.47%
MAGEE THOMSON INVESTMENT PARTNERS LLC 126,022$12,214,0003.01%
NEXT CENTURY GROWTH INVESTORS LLC 768,396$74,472,0002.63%
MARXE AUSTIN W & GREENHOUSE DAVID M 180,000$17,446,0002.38%
Lisanti Capital Growth, LLC 48,280$4,679,0002.35%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 79,017$7,658,0002.00%
Atika Capital Management LLC 21,500$2,084,0001.60%
View complete list of PACIRA PHARMACEUTICALS INC shareholders